INDUSTRIES

Pharma & Life Sciences

Navigate regulatory complexities, enhance product safety, and bring innovative therapies to market with Glocert International's specialized quality management and compliance solutions for pharma and life sciences organizations.

Why Pharma & Life Sciences is Different

Pharma and life sciences organizations operate in one of the most heavily regulated industries globally, with strict requirements for product safety, quality, and efficacy. The combination of GMP regulations, FDA/EU MDR oversight, clinical trial requirements, supply chain complexity, and data integrity obligations creates unique compliance challenges that require specialized expertise and industry-specific solutions.

Regulatory Obligations

Pharma and life sciences organizations must navigate multiple regulatory frameworks including FDA (US), EU MDR/IVDR (Europe), GMP requirements, ICH guidelines, and local pharmaceutical regulations. Understanding which regulations apply and how they intersect is critical for maintaining compliance, avoiding regulatory actions, and bringing products to market successfully across different jurisdictions.

Common Compliance Mistakes

Many pharma organizations make critical mistakes including treating quality management as a compliance exercise rather than a business system, implementing data integrity controls without aligning with manufacturing processes, ignoring supplier and contract manufacturer risk, and failing to maintain continuous compliance between inspections. Understanding these common pitfalls helps organizations avoid costly regulatory actions and product recalls.

75+ Pharma Organizations Served
98% Client Satisfaction Rate
15+ Countries Served
15+ Years of Experience

Regulatory Obligations

Understanding which regulations apply to your pharma or life sciences organization and how they intersect is critical for maintaining compliance and bringing products to market successfully.

Mandatory Requirements

FDA (US): Required for all pharmaceutical manufacturers, drug developers, and medical device companies operating in the US. Non-compliance can result in Warning Letters, import alerts, and facility shutdowns.

EU MDR/IVDR: Required for all medical device and IVD manufacturers marketing products in the European Union, replacing the previous MDD/IVDD directives.

GMP: Good Manufacturing Practice requirements are mandatory for pharmaceutical manufacturing facilities globally, ensuring product quality and safety.

Commonly Required

ICH Guidelines: International Council for Harmonisation guidelines provide standards for pharmaceutical development, quality, safety, and efficacy across major markets.

ISO 13485: Widely adopted quality management standard for medical device manufacturers, often required by regulatory authorities and customers.

ISO 17025: Required for testing and calibration laboratories supporting pharmaceutical development and manufacturing, ensuring reliable test results.

Emerging Requirements

Data integrity: Increasing focus on ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available) for pharmaceutical data.

Cybersecurity: Enhanced requirements for protecting pharmaceutical manufacturing systems, clinical trial data, and connected medical devices from cyber threats.

Supply chain security: Growing emphasis on supplier qualification, risk management, and traceability in pharmaceutical supply chains.

Commonly Adopted Certifications

These certifications help pharma and life sciences organizations demonstrate compliance, ensure product quality, and build stakeholder trust.

ISO 13485

For medical device manufacturers. Ensures quality management systems meet regulatory requirements for medical devices, supporting FDA and EU MDR compliance.

Learn More

ISO 17025

For testing and calibration laboratories. Ensures laboratory competence and reliable test results, critical for pharmaceutical development and quality control.

Learn More

ISO 15189

For medical laboratories. Ensures quality and competence of medical laboratories, supporting accurate diagnostic and clinical trial results.

Learn More

ISO/IEC 9001

For quality management systems. Provides a framework for quality management across pharmaceutical operations, supporting GMP compliance.

Learn More

ISO/IEC 27001

For information security governance. Protects sensitive pharmaceutical data including clinical trial data, intellectual property, and manufacturing systems.

Learn More

ISO 22301

For business continuity. Ensures continuity of pharmaceutical manufacturing and supply chain operations during disruptions, protecting patient access to medicines.

Learn More

ISO 14001

For environmental management. Manages environmental impacts of pharmaceutical manufacturing, ensuring compliance with environmental regulations.

Learn More

ISO 45001

For occupational health and safety. Protects worker safety in pharmaceutical manufacturing facilities, ensuring safe working conditions.

Learn More

Common Compliance Mistakes

Understanding these common pitfalls helps pharma and life sciences organizations avoid costly regulatory actions and build more effective quality and compliance programs.

Treating Quality as a Compliance Exercise

Many organizations implement quality management systems as a compliance requirement rather than a business system. Quality must be integrated into operations, not treated as a separate compliance function, to ensure product safety and efficacy.

Data Integrity Without Process Alignment

Implementing data integrity controls without aligning with manufacturing and laboratory processes leads to workarounds, data manipulation, and compliance failures. Data integrity must be built into processes, not added as an afterthought.

Ignoring Supplier and Contract Manufacturer Risk

Pharma organizations often focus on internal quality while overlooking suppliers, contract manufacturers, and raw material vendors. These represent significant quality and regulatory risks that must be assessed, qualified, and monitored continuously.

Failing to Maintain Continuous Compliance

Many organizations prepare for regulatory inspections only when scheduled, leading to gaps, inconsistencies, and compliance failures. Continuous compliance monitoring and maintenance are essential for effective quality management.

Inadequate Change Control and Validation

Pharma organizations often fail to properly control changes to manufacturing processes, equipment, and systems, or validate changes appropriately. Inadequate change control and validation can lead to product quality issues and regulatory actions.

Insufficient CAPA Management

Many organizations have Corrective and Preventive Action (CAPA) systems that are not effective, not integrated with quality systems, or fail to address root causes. Effective CAPA management is critical for continuous improvement and regulatory compliance.

How Glocert Supports Pharma & Life Sciences Organizations

Glocert supports pharma and life sciences organizations through independent certification, assurance, and audit services aligned to international standards and pharmaceutical regulations.

Our pharma and life sciences compliance services include ISO 13485 certification for medical device quality management, ISO 17025 certification for testing and calibration laboratories, ISO 15189 certification for medical laboratories, ISO 9001 certification for quality management systems, ISO 27001 certification for information security, and pharmaceutical quality audits to ensure regulatory compliance and product quality.

We understand the unique challenges of pharma and life sciences organizations including regulatory complexity, product safety requirements, data integrity obligations, supply chain management, and continuous compliance. Our auditors bring deep pharmaceutical industry expertise and work with you to build quality and compliance programs that integrate with operations, ensure product quality, and meet regulatory requirements across multiple jurisdictions.

Frequently Asked Questions

Do pharma organizations need both ISO 13485 and FDA compliance?
Yes, medical device manufacturers typically need both. FDA compliance is a legal requirement for medical devices marketed in the US, while ISO 13485 provides a comprehensive quality management framework. ISO 13485 can help demonstrate FDA compliance more effectively, and many organizations use ISO 13485 as the foundation for their FDA quality system. ISO 13485 is also often required by customers and regulatory authorities in other markets.
How does ISO 17025 relate to pharmaceutical quality control?
ISO 17025 ensures laboratory competence and reliable test results, which is critical for pharmaceutical quality control. Testing laboratories supporting pharmaceutical development and manufacturing must produce accurate, reliable results to ensure product quality and regulatory compliance. ISO 17025 certification demonstrates laboratory competence and is often required by regulatory authorities and customers. Many pharmaceutical organizations require their testing laboratories to achieve ISO 17025 certification.
What is the difference between ISO 13485 and ISO 9001 for medical devices?
ISO 13485 is specifically designed for medical device quality management systems and includes requirements specific to medical devices such as risk management, design controls, and regulatory requirements. ISO 9001 is a general quality management standard. While ISO 9001 can be applied to medical devices, ISO 13485 is the preferred standard for medical device manufacturers as it addresses medical device-specific requirements and is often required by regulatory authorities and customers. Many medical device manufacturers pursue ISO 13485 rather than ISO 9001.
How do data integrity requirements affect pharmaceutical operations?
Data integrity is critical in pharma given regulatory focus on ALCOA+ principles. Pharmaceutical organizations must ensure data is Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available. This requires appropriate controls for data generation, recording, storage, and retrieval. Data integrity failures can lead to regulatory actions, product recalls, and loss of regulatory approval. ISO 27001 helps establish information security controls that support data integrity, while GMP requirements specifically address data integrity in pharmaceutical manufacturing.
What are the implications of contract manufacturing for compliance?
Contract manufacturing introduces additional compliance considerations. Pharmaceutical organizations remain responsible for product quality and regulatory compliance even when manufacturing is outsourced. Organizations must qualify contract manufacturers, ensure appropriate quality agreements are in place, monitor contract manufacturer compliance, and have appropriate oversight. Many pharmaceutical organizations require contract manufacturers to achieve ISO 13485 or ISO 9001 certification to demonstrate quality capabilities. Failure to properly manage contract manufacturers is a common compliance mistake.
How should pharma organizations approach supplier qualification?
Supplier qualification is critical in pharma given reliance on suppliers for raw materials, components, and services. Organizations should assess supplier quality capabilities, require appropriate certifications (ISO 9001, ISO 13485), ensure quality agreements are in place, monitor supplier compliance, and have appropriate oversight. Many pharmaceutical organizations require suppliers to achieve ISO 9001 or ISO 13485 certification to demonstrate quality capabilities. Supplier qualification must be ongoing, not a one-time activity, and organizations must monitor supplier performance continuously.
What are the cybersecurity considerations for pharmaceutical organizations?
Cybersecurity is increasingly important in pharma given reliance on digital systems for manufacturing, clinical trials, and data management. Pharmaceutical organizations must protect manufacturing systems, clinical trial data, intellectual property, and connected medical devices from cyber threats. ISO 27001 helps establish information security controls, while regulatory authorities are increasingly focusing on cybersecurity for pharmaceutical systems. Many pharmaceutical organizations pursue ISO 27001 certification to demonstrate cybersecurity capabilities and protect sensitive data.
How do pharma organizations ensure continuous compliance between inspections?
Continuous compliance requires ongoing monitoring, maintenance, and improvement of quality systems. Organizations should implement internal audit programs, conduct management reviews, monitor quality metrics, maintain documentation, and address non-conformances promptly. ISO 13485 and ISO 9001 provide frameworks for continuous improvement and compliance maintenance. Many organizations struggle with maintaining compliance between regulatory inspections, making continuous compliance monitoring essential. Regular internal audits and management reviews help ensure systems remain compliant and effective.

Get started with
Glocert International

Are you ready to navigate regulatory complexities and achieve compliance excellence? Glocert International is ready to assist with quality management, compliance, and certification solutions tailored to your pharma or life sciences organization.